Abstract
High-altitude pulmonary edema (HAPE) is a form of lung edema which occurs in otherwise healthy subjects, thereby allowing the study of underlying mechanisms of pulmonary edema in the absence of confounding factors. Exaggerated pulmonary hypertension is a hallmark of HAPE and is thought to play an important part in its pathogenesis. Pulmonary vascular endothelial dysfunction and augmented hypoxia-induced sympathetic activation may be underlying mechanisms contributing to exaggerated pulmonary vasoconstriction in HAPE. Recent observations by our group suggest, however, that pulmonary hypertension itself may not be sufficient to trigger HAPE. Based on studies in rats, indicating that perinatal exposure to hypoxia predisposes to exaggerated hypoxic pulmonary vasoconstriction in adulthood, we examined effects of high-altitude exposure on pulmonary-artery pressure in a group of young adults who had suffered from transient perinatal pulmonary hypertension. We found that these young adults had exaggerated pulmonary vasoconstriction of similar magnitude to that observed in RAPE-susceptible subjects. Surprisingly, however, none of the subjects developed lung edema. These findings strongly suggest that additional mechanisms are needed to trigger pulmonary edema at high-altitude. Observations in vitro, and in vivo suggest that a defect of the alveolar transepithelial sodium transport could act as a sensitizer to pulmonary edema. The aim of this article is to review very recent experimental evidence consistent with this concept. We will discuss data gathered in mice with targeted disruption of the gene of the α subunit of the amiloride-sensitive epithelial sodium channel (αENaC), and present preliminary data on measurements of transepithelial sodium transport in vivo in HAPE-susceptible and HAPE-resistant mountaineers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barker, D. J. P. Mothers, babies, and disease in later life. London: BMJ Books, 1994.
Blitzer, M. L., E. Loh, M. A. Roddy, J. S. Stamler, and M. A. Creager. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol 28: 591–6, 1996.
Canessa, C. M., J. D. Horisberger, and B. C. Rossier. Epithelial sodium channel related to proteins involved in neurodegeneration. Nature 361: 467–70, 1993.
Canessa, C. M., L. Schild, G. Buell, B. Thorens, I. Gautschi, J. D. Horisberger, and B. C. Rossier. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367: 463–7, 1994.
Caslin, A., D. Heath, and P. Smith. Influence of hypobaric hypoxia in infancy on the subsequent development of vasoconstrictive pulmonary vascular disease in the Wistar albino rat. J Pathol 163: 133–111, 1991.
Chen, S.-J., Y.-F. Chen, Q. C. Meng, and S. Oparil. The endothelin receptor antagonist Bosentan prevents short term hypoxia induced pulmonary hypertension in the rats (Abstract). Circulation 90: I-151, 1994.
Dauber, I. M., and J. V. Weil. Lung injury edema in dogs. Influence of sympathetic ablation. J Clin Invest 72: 1977–86, 1983.
DiCarlo, V. S., S. J. Chen, Q. C. Meng, J. Durand, M. Yano, Y. F. Chen, and S. Oparil. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am J Physio 1269: L690–7, 1995.
Dinh-Xuan, A. T., T. W. Higenbottam, C. A. Clelland, J. Pepke-Zaba, G. Cremona, A. Y. Butt, S. R. Large, F. C. Wells, and J. Wallwork. Impairment of endothelium-dependent pulmonaryartery relaxation in chronic obstructive lung disease. N Engl J Med 324: 1539–47, 1991.
Duplain, H., K. L. Peterson, M. Lepori, C. Sartori, E. Hummler, P. Nicod, and U. Scherrer. Augmented hypoxic pulmonary vasoconstriction and increased susceptibility to lung edema in heterozygous endothelial nitric oxide synthase (eNOS) deficient mice (Abstract). Am J Respir Crit Care Med 159: A355, 1999.
Duplain, H., L. Vollenweider, A. Delabays, P. Nicod, P. Bartsch, and U. Scherrer. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 99: 1713–8, 1999.
Fagan, K. A., B. W. Fouty, R. C. Tyler, K. G. Morris, Jr., L. K. Hepler, K. Sato, T. D. LeCras, S. H. Abman, H. D. Weinberger, P. L. Huang, I. F. McMurtry, and D. M. Rodman. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest 103: 291–9, 1999.
Frostell, C., M.-D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. Inhaled nitric oxide. A selected pulmonary vasodilatator reversing hypoxie pulmonary vasoconstriction. Circulation 83: 2038–2047, 1991.
Frostell, C. G., H. Blomqvist, G. Hedenstierna, J. Lundberg, and W. M. Zapol. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427–35, 1993.
Goerre, S., M. Wenk, P. Bärtsch, T. F. Luescher, F. Niroomand, E. Hohenhaus, O. Oelz, and W. H. Reinhart. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 90: 359–364, 1995.
Hackett, P. H., and R. C. Roach. High altitude pulmonary edema. J Wilderness Med 1:3–26, 1990.
Hackett, P. H., R. C. Roach, G. S. Hartig, E. R. Greene, and B. D. Levine. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison. Int J Sports Med 13: 568–71, 1992.
Hampl, V., and J. Herget. Perinatal hypoxia increases hypoxie pulmonary vasoconstriction in adult rats recovering from chronic exposure to hypoxia. Am Rev Respir Dis 142: 619–24, 1990.
Haworth, S. G. Pulmonary vascular remodeling in neonatal pulmonary hypertension. State of the art. Chest 93: 1335–1385, 1988.
Hultgren, H. N. High altitude pulmonary edema. In: Lung Water and Solute Exchange, edited by N. C. Staub. New York, NY: Dekker, 1978, p. 437–469.
Hultgren, H. N. High-altitude pulmonary edema: current concepts. Annu Rev Med 47: 267–84, 1996.
Hummler, E., P. Barker, J. Gatzy, F. Beermann, C. Verdumo, A. Schmidt, R. Boucher, and B. C. Rossier. Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet 12: 325–8, 1996.
Hummler, E., P. Barker, C. Talbot, Q. Wang, C. Verdumo, B. Grubb, J. Gatzy, M. Burnier, J. D. Horisberger, F. Beermann, R. Boucher, and B. C. Rossier. A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism. Proc Natl Acad Sci U S A 94: 11710–5, 1997.
Knowles, M. R., W. H. Buntin, P. A. Bromberg, J. T. Gatzy, and R. C. Boucher. Measurements of transepithelial electric potential differences in the trachea and bronchi of human subjects in vivo. Am Rev Respir Dis 126: 108–12, 1982.
Knowles, M. R., J. L. Carson, A. M. Collier, J. T. Gatzy, and R. C. Boucher. Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am Rev Respir Dis 124: 484–90, 1981.
Kourembanas, S., L. P. McQuillan, G. K. Leung, and D. V. Faller. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 92: 99–104, 1993.
Krasney, J. A. A neurogenic basis for acute altitude illness. Med Sci Sports Exerc 26: 195–208, 1994.
Lepori, M., E. Hummler, F. Feihl, C. Sartori, P. Nicod, B. Rossier, and U. Scherrer. Amiloride sensitive sodium transport dysfunction augments susceptibility to hypoxia-induced lung edema (Abstract). FASEB J 12: A328, 1998.
Matthay, M. A., H. G. Folkesson, and A. S. Verkman. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physio 1270: L487–503, 1996.
Morin, F. C., 3rd, and K. R. Stenmark. Persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 151: 2010–32, 1995.
Planes, C., B. Escoubet, M. Blot-Chabaud, G. Friedlander, N. Farman, and C. Clerici. Hypoxia downregulates expression and activity of epithelial sodium channels in rat alveolar epithelial cells. Am J Respir Cell Mol Biol 17: 508–18, 1997.
Rabinovitch, M., W. J. Gamble, O. S. Miettenen, and L. Reid. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 240: H62–H72, 1981.
Sakuma, T., G. Okaniwa, T. Nakada, T. Nishimura, S. Fujimura, and M. A. Matthay. Alveolar fluid clearance in the resected human lung. Am J Respir Crit Care Med 150: 305–10, 1994.
Sartori, C., Y. Allemann, L. Trueb, A. Delabays, P. Nicod, and U. Scherrer. A perinatal vascular insult predisposes to augmented vasoreactivity in adult life (In Press). Lancet, 1999.
Sartori, C., M. Lepori, M. Maggiorini, Y. Allemann, P. Nicod, and U. Scherrer. Impairment of amiloride-sensitive sodium transport in individuals susceptible to high altitude pulmonary edema (Abstract). FASEB J 12: A231, 1998.
Sartori, C., L. Trueb, and U. Scherrer. High-altitude pulmonary edema. Mechanisms and management. Cardiologia 42: 559–67, 1997.
Sartori, C., L. Vollenweider, B. M. Loftier, A. Delabays, P. Nicod, P. Bartsch, and U. Scherrer. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation 99: 2665–8, 1999.
Saumon, G., and G. Basset. Electrolyte and fluid transport across the mature alveolar epithelium. J Appl Physiol 74: 1–15, 1993.
Scherrer, U., L. Vollenweider, A. Delabays, M. Savcic, U. Eichenberger, G. R. Kleger, A. Fikrle, P. E. Ballmer, P. Nicod, and P. Bartsch. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 334: 624–629, 1996.
Schoene, R. B. Pulmonary edema at high altitude: Review, pathophysiology and update. Clin Chest Med 6: 491–507, 1985.
Smith, A. P. L., C. J. Emery, and T. W. Higenbottam. Perinatal chronic hypoxia decreases endothelial nitric oxide synthase (NOS III) and increases preproendothelin-1 (ppET-1) mRNA levels in rat (Abstract). Eur Respir J 10: 433s, 1997.
Staub, N. C. Pulmonary edema. Physiol Rev 54: 678–811, 1974.
Staub, N. C. Pulmonary edema--hypoxia and overperfusion (Editorial). N.Engl.J.Med. 302: 1085–1086, 1980.
Stenmark, K. R., E. C. Orton, J. T. Reeves, N. F. Voelkel, E. C. Crouch, W. C. Parks, and R. P. Mecham. Vascular remodeling in neonatal pulmonary hypertension. Role of the smooth muscle cell. Chest 93: 127S–133S, 1988.
Steudel, W., M. Scherrer-Crosbie, K. D. Bloch, J. Weimann, P. L. Huang, R. C. Jones, M. H. Picard, and W. M. Zapol. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 101: 2468–77, 1998.
Suzuki, S., Y. Hoshikawa, S. Ono, T. Sakuma, K. Koike, T. Tanita, and S. Fujimura. [Effects of subacute hypoxia on alveolar epithelial ion transport in rats]. Nihon Kyobu Shikkan Gakkai Zasshi 34: 52–6, 1996.
West, J. B., and O. Mathieu Costello. High altitude pulmonary edema is caused by stress failure of pulmonary capillaries. Int JSports Med 13: S54–8, 1992.
Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–5, 1988.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Scherrer, U. et al. (1999). High-Altitude Pulmonary Edema: From Exaggerated Pulmonary Hypertension to a Defect in Transepithelial Sodium Transport. In: Roach, R.C., Wagner, P.D., Hackett, P.H. (eds) Hypoxia. Advances in Experimental Medicine and Biology, vol 474. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4711-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4711-2_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7134-2
Online ISBN: 978-1-4615-4711-2
eBook Packages: Springer Book Archive